Comparing Stigma in Lung Cancer to Other Tobacco-Related Cancers: A Study from End Lung Cancer Now

B
Bharathi Muthusamy

Primary Investigator

Enrolling By Invitation
18 years - 100 years
All
Phase N/A
3 Locations

Brief description of study

What is the purpose of this study?
This is a descriptive, cross-sectional study, which will involve a one-time survey for patients with lung cancer (any histology), pancreatic adenocarcinoma, renal cell carcinoma, and urothelial carcinoma. 
 
Patients in this study will be recruited in a prospective basis during their in-person visit to the outpatient Multi-D Subspecialty Oncology Clinic visits at Indiana University Simon Comprehensive Cancer Center and oncology clinic at Eskenazi Hospital.
 
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic. 
 
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office 
Phone: (317) 278-5632

Detailed description of study

What will happen during the study?

This is a descriptive, cross-sectional study, which will involve a one-time survey for patients with lung cancer (any histology), pancreatic adenocarcinoma, renal cell carcinoma, and urothelial carcinoma.  The goal of the survey is to capture the patient’s demographics (age, gender, etc.), smoking status, and PCRS. ECOG performance status, stage of disease, point in treatment, and date of diagnosis will be collected from the EMR for each of the patients.
 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lung Cancer, pancreatic Adenocarcinoma, Eenal cell carcinoma, Urothelial carcinoma.
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria:
• 18 years or older at the time of informed consent
• Any stage of lung cancer (any histology), pancreatic adenocarcinoma, renal cell
carcinoma, and urothelial carcinoma.
• Able to read and write in English or Spanish.
• Able to provide written informed consent.
• No mental disability which would preclude completion of questionnaires.

Exclusion Criteria:
• Inability to provide informed consent.
• Inability to complete the survey.
• Primarily Spanish-speaking with any other cancer besides lung cancer.
• Patient with multiple primary cancers

Updated on 06 Feb 2025. Study ID: CTO-IUSCCC-0868, 23921
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center